The FibroScan alternative for Australian clinicians
FibroScan works. But it's not the only option — and for many Australian practices, it's not the best one.
The problem with blind point-and-shoot elastography
Traditional transient elastography (TE) devices like standard FibroScan models operate "blind." The clinician places the probe using external anatomical landmarks and fires an acoustic pulse, hoping to hit a clean window of liver parenchyma.
In lean patients, this works well. But in patients with a BMI > 30 — the exact cohort driving the MAFLD epidemic in Australia — blind acquisition struggles. The skin-to-liver distance increases, and the acoustic pulse often hits ribs, vessels, or lung tissue.
What "Unreliable IQR" looks like in practice
When blind systems fail to get a clean reading, they return high Interquartile Range (IQR) variations or fail to generate a stiffness value entirely. This forces the clinician to switch to an XL probe (an additional capital cost) or abandon the scan, leaving the patient without a fibrosis stage.
The guided alternative: iLivTouch 2D SWE
Real-time imaging. One universal probe. 96.5% success rate in NAFLD cohorts.
See before you scan
Real-time B-mode ultrasound guidance lets you visualize the liver parenchyma, avoid large vessels, and target the perfect measurement window every time.
Universal probe
A single wideband frequency probe automatically adapts to patient depth. No need to purchase, maintain, or switch between M and XL probes mid-consultation.
Half the CapEx
Advanced guided elastography is supplied at roughly half the capital cost of traditional blind systems, dramatically accelerating your clinic's ROI.
Head-to-head comparison
| Feature | Elastography Australia (iLivTouch) | FibroScan (Standard TE) |
|---|---|---|
| Guidance | Real-time 2D Ultrasound | Blind (A-mode pulse only) |
| Probes Required | 1 (Universal) | 2+ (M and XL sold separately) |
| Fibrosis Output | LSM (kPa) | LSM (kPa) |
| Steatosis Output | UAP (dB/m) | CAP (dB/m) |
| Capital Cost | ~$45k AUD | $90k+ AUD |
3 scenarios when you should switch
New Clinic Setup
If you are establishing a new hepatology service, imaging centre, or GP metabolic clinic, committing $90k+ to legacy blind technology creates an unnecessary ROI burden. Guided elastography halves your break-even timeframe.
High-BMI Cohorts
If your practice manages a high volume of MAFLD, obesity, or type 2 diabetes, you need a device that doesn't fail when the skin-to-liver distance increases. 2D guidance is essential for this demographic.
Previous TE Failures
If your clinic is frustrated by high IQR ratios, abandoned scans, or the constant need to switch to an XL probe, upgrading to a guided system restores clinical confidence and workflow efficiency.
Ready to evaluate the alternative?
See the difference 2D guidance makes in your own clinic. Request a demonstration or pricing information today.
Request a Demo